Compounds > organophosphonates
Page last updated: 2024-09-05

organophosphonates and cardiovascular agents

organophosphonates has been researched along with cardiovascular agents in 3 studies

Compound Research Comparison

Studies
(organophosphonates)		Trials
(organophosphonates)		Recent Studies (post-2010)
(organophosphonates)		Studies
(cardiovascular agents)		Trials
(cardiovascular agents)		Recent Studies (post-2010) (cardiovascular agents)
9,9688803,59617,6451,4806,891

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Budriesi, R; Chiarini, A; Ferranti, A; Garuti, L; Katz, E; Roberti, M1
Chen, V; Diakur, JM; Friesen, AD; Froese, D; Haque, W; Pham, V; Whitney, T; Yao, J; Zhang, W1
Ayach, B; Battistini, B; Blouin, A; Cernacek, P; Jeng, AY; Opgenorth, T; Tsang, J; Verreault, M; Wessale, J1

Other Studies

3 other study(ies) available for organophosphonates and cardiovascular agents

ArticleYear
Synthesis and biological evaluation of some new phosphonates.
    Die Pharmazie, 1992, Volume: 47, Issue:4

    Topics: Animals; Cardiovascular Agents; Guinea Pigs; Heart Rate; In Vitro Techniques; Myocardial Contraction; Organophosphonates

1992
Design and synthesis of novel pyridoxine 5'-phosphonates as potential antiischemic agents.
    Journal of medicinal chemistry, 2003, Aug-14, Volume: 46, Issue:17

    Topics: Animals; Cardiovascular Agents; Coronary Stenosis; Drug Stability; Fatty Acids; Glucose; Glycolysis; In Vitro Techniques; Lethal Dose 50; Light; Molecular Mimicry; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Organophosphonates; Oxidation-Reduction; Pyridoxal Phosphate; Rats; Rats, Sprague-Dawley; Rats, Wistar; Structure-Activity Relationship; Toxicity Tests, Acute

2003
Role of the endothelin system in secondary pulmonary hypertension related to air embolism: lessons learned from testing four classes of endothelin blockers in a rat model.
    Journal of cardiovascular pharmacology, 2004, Volume: 44 Suppl 1

    Topics: Acute Disease; Animals; Aspartic Acid Endopeptidases; Atrasentan; Benzofurans; Cardiovascular Agents; Disease Models, Animal; Embolism, Air; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-Converting Enzymes; Endothelins; Hemodynamics; Hypertension, Pulmonary; Male; Metalloendopeptidases; Organophosphonates; Protease Inhibitors; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Sulfonamides; Time Factors; Ventricular Dysfunction, Right

2004